
Brazil’s antitrust watchdog CADE said on Friday that the sale of state-run oil company Petrobras’ Reman refinery to fuel distributor Atem was approved with no restrictions.
Reuters had reported the regulator’s approval of the deal on Thursday, citing sources.
Petroleo Brasileiro SA, as the company is formally known, had announced in August 2021 an agreement to sell the refinery, which is located in the northern state of Amazonas, for $189.5 million.
The sale still needed to be approved by CADE. Reman is one of eight refineries the company has put up for sale as part of a 2019 agreement with the antitrust regulator to enhance competition in Brazil’s oil refining sector.
CADE said in a statement that the approval came as its general superintendence considered that Atem would not be able to absorb all of Reman’s gasoline and diesel output on its own, adding that the company will also look to expand the plant’s production.
“No incentive was found for Atem to close distribution to competitors, given that there is a high investment in the refinery that will need to be recovered and other alternatives for distributors to source their products,” CADE said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas